West Nile virus vaccine may be ready by the end of the year

NewsGuard 100/100 Score

A Dutch biotechnology manufacturer says it has identified a human antibody which has proven effective against West Nile virus in animal studies.

The firm Crucell say that their study results have shown that the fully human monoclonal antibody, derived from patients who survived West Nile infection, effectively neutralized the virus in cell culture and fully protected mice from the lethal infection.

Significant progress has also been reported by Crucell in developing vaccines against Ebola and SARS.

The West Nile virus vaccine development program will begin clinical trials at the end of this year.

West Nile virus which is carried by mosquitos, first appeared in New York in 1999, and has since spread throughout the United States.

In 2004, there were 2,470 recorded cases of the disease and 88 fatalities caused by a form of encephalitis, or inflammation of the brain.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies